About 500 reports

  • 5.3 TREATMENT GUIDELINES AND LEADING PRESCRIBED DRUGS
  • 3.2 CLASSIFICATION

BIPOLAR DISORDERS; ##(##): ##- ##.

  • Hospital
  • World
  • Market Size
  • AstraZeneca PLC
  • Otsuka Pharmaceutical Co., Ltd.
  • 2.3 UPCOMING RELATED REPORTS
  • 3.6.2 Limitations of the Analysis

Journal of Affective Disorders; ##: ##-##.

  • Hospital
  • Japan
  • United States
  • World
  • Forecast

Neurology Market: A BCC Research Overview Chapter ## Introduction Study Goals and Objectives Reasons for Doing this Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Technology Background Neu

  • Hospital
  • Therapy
  • World
  • Market Shares
  • Market Size
  • CENTRAL NERVOUS SYSTEM THERAPEUTIC MARKET : PRODUCT OUTLOOK

Most common type of mental health disorders are: attention deficit hyperactivity disorder, anxiety, mood disorders, schizophrenia, dementia, bipolar disorder etc.

  • Hospital
  • World
  • AstraZeneca PLC
  • Biogen Idec Inc.
  • Eli Lilly & Co.

Diagnostic and Statistical Manual of Mental Disorders (DSM) have outlined four types of bipolar including, bipolar I disorder is diagnosed when a person displays manic or mixed ##. ##. ## BIPOLAR DISORDERS episodes that last at least seven da

  • Hospital
  • World
  • Market Size
  • Compumedics Limited
  • Medtronic, Inc.

THIS SENSOR TRACKS DRUG INGESTION IN PATIENTS WITH MENTAL ILLNESS OR DISORDERS SUCH AS SCHIZOPHRENIA AND BIPOLAR I DISORDER.

  • Hospital
  • World
  • Market Size
  • Analog Devices, Inc.
  • Honeywell International Inc.
  • 5.2 RISK FACTORS AND COMORBIDITIES

ONE STUDY FOUND AN ASSOCIATION BETWEEN MIGRAINE AND BIPOLAR DISORDER (OR = ##. ##, ##% CI = ##. ##-##. ##).

  • Hospital
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • NEUROLOGY DEVICES

THESE DEVICES ARE USED FOR RELIEVING DEPRESSION, TRAUMATIC BRAIN INJURY, STRESS AND BIPOLAR DISORDERS BY MANIPULATING BRAIN SIGNALS ACCORDINGLY.

  • Hospital
  • World
  • Demand
  • Market Size
  • Becton Property Group
  • FEB 28, 2018: LITHIUM TREATMENT FOR BIPOLAR DISORDER LINKED TO LOWEST RISK OF REHOSPITALISATION

More than one percent of the world' s population is affected by bipolar disorder.

  • Cancer
  • Hospital
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

Zyprexa is used for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder and bipolar maintenance.

  • Hospital
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Lilly Endowment Inc.
  • Pfizer Inc.
  • FEB 08, 2018: AUTISM, SCHIZOPHRENIA, BIPOLAR DISORDER SHARE MOLECULAR TRAITS, STUDY FINDS

Serious mental illnesses include schizophrenia, bipolar disorder and recurrent major depressive disorder.

  • Cancer
  • Hospital
  • Medical Biotechnology
  • Therapy
  • United States
  • Central Nervous System Drugs Market Characteristics

bipolar disorders and anxiety.

  • Hospital
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Pfizer Inc.

Pyschiatric Hospitals specialize in the treatment of serious mental disorders such as clinical depression, schizophrenia, and bipolar disorder.

  • Hospital
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.

Mental health conditions such as anxiety, psychosis, bipolar disorder (BD), schizophrenia, posttraumatic stress disorder (PTSD), alcoholism, and emotional and behavioral disorders are the most common conditions that require home healthcare services.

  • Hospital
  • World
  • Forecast
  • Johnson & Johnson
  • Omron Corporation
  • PROPORTION OF BIPOLAR DISORDER (MANIC DEPRESSION) TO CENTRAL NERVOUS SYSTEM CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF BIPOLAR DISORDER (MANIC DEPRESSION) TO CENTRAL NERVOUS SYSTEM CLINICAL TRIALS

BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) TH

  • Clinical Trial
  • Depression
  • Hospital
  • Neurology
  • World

Target areas include obesity, smoking, diabetes, depression, anxiety, bipolar disorder, and schizophrenia.

  • Hospital
  • Medtronic, Inc.
  • Microsoft Corporation
  • Qualcomm Incorporated
  • Symantec Corporation

WHILE AT NIMH, HIS AREA OF RESEARCH WAS FOCUSING ON THE NEUROBIOLOGY OF DEPRESSION AND BIPOLAR DISORDER.

  • Hospital
  • Australasia
  • Australia
  • Oceania
  • Medtronic, Inc.
  • OTHERS

ECT electrodes are used for the treatment of disorders such as bipolar disorder, schizophrenia, catatonic stupor, psychotic depression, and others.

  • Cardiovascular Disease
  • Hospital
  • World
  • Forecast
  • Medtronic, Inc.
  • 2.2 UPCOMING REPORTS
  • 3.2 RISK FACTORS AND COMORBIDITIES

One study found an association between migraine and bipolar disorder (OR = ##. ##, ##% CI = ##. ##-##. ##).

  • Hospital
  • Japan
  • United States
  • World
  • Forecast
  • TECHNOLOGY AND SYSTEMS
  • PUBLIC PSYCHIATRIC HOSPITALS

Particular issues treated include manic episodes, bipolar disorder, depressive episodes and recurrent depression.

  • Health Services
  • Hospital
  • Specialty Hospital
  • Australia
  • Demand

In the same month, Otsuka Canada Pharmaceutical, a subsidiary of Otsuka, and Lundbeck Canada secured an approval from Health Canada for Abilify Maintena to treat bipolar I disorder in adult patients.

  • Hospital
  • Japan
  • Market Size
  • Roche Group
  • Terumo Corporation
  • Products and services segmentation (2018-19)
  • PRODUCTS AND SERVICES CONTINUED

Common mental health conditions that psychiatrists treat include depression, eating disorders such as anorexia and bulimia, bipolar disorders, schizophrenia, dementia and post-traumatic stress disorder.

  • Health Services
  • Hospital
  • Australia
  • Demand

The Innsbruck Medical University based in Austria is focusing on research for disease areas such as schizophrenia, bipolar disorder, Parkinson' s, and Alzheimer.

  • Hospital
  • Austria
  • Market Size
  • Medtronic, Inc.
  • Roche Group

In addition, individuals with a bipolar disorder (i. e. manic depression) who maintain a regimen of lithium are much less likely to relapse than those not taking the medication.

  • Addiction Disorder
  • Hospital
  • Mental Health
  • United States
  • Demand

Source: Technavio MARKET OVERVIEW ULTRASONIC ASPIRATOR MARKET IN EMEA The incidence rate of neurological disorders, such as dementia, bipolar disorder, and cerebral palsy, is high in the region.

  • Hospital
  • World
  • Demand
  • Forecast
  • Olympus Corporation

LAMICTAL HAS ALSO BEEN APPROVED FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER IN THE US, AND THE PREVENTION OF DEPRESSIVE EPISODES IN PATIENTS WITH BIPOLAR I DISORDER IN THE EU AND JAPAN (GSK, 2003).

  • Hospital
  • United States
  • Forecast
  • Eisai Co., Ltd.
  • GW Pharmaceuticals plc

IN ADDITION TO ASSESSING ESTABLISHED RISK FACTORS, THE ALGORITHM NOW TAKES INTO ACCOUNT NEW RISK FACTORS INCLUDING: ATYPICAL ANTIPSYCHOTICS, STATINS, SCHIZOPHRENIA OR BIPOLAR AFFECTIVE DISORDER, LEARNING DISABILITY, GESTATIONAL DIABETES, AND POLYCYSTIC OVARY SYNDROME.

  • Hospital
  • Northern Europe
  • United Kingdom
  • Market Size
  • LiDCO Group Plc

Other risk factors for diabetes could be a heart attack or stroke, alcohol consumption, smoking, bipolar disorder, depression, receiving treatment with antipsychotic medication for schizophrenia, and woman with polycystic ovaries.

  • Hospital
  • World
  • Forecast
  • B. Braun Medical
  • Teleflex Incorporated

These apps are designed to help patients with anxiety, bipolar disorder, mood disorders, and stress.

  • Hospital
  • North America
  • United States
  • Market Size
  • Cerner Corporation

LITHIUM IS USED OFF-LABEL FOR FXS, AS THE PRIMARY INDICATION IS FOR BIPOLAR DISORDER.

  • Hospital
  • United States
  • Marinus Pharmaceuticals, Inc.
  • Neuren Pharmaceuticals Limited
  • Zynerba Pharmaceuticals, Inc.